10 Must-Read Articles For #ECTRIMS2015

Click here to receive MS news via e-mail

Here is what you need to read before #ECTRIMS2015

1.       Could Genentech’s Ocrelizumab Become the First Effective Primary Progressive MS Therapy?


2.      Ocrelizumab: a Promising New Treatment for Multiple Sclerosis with Minimal Side Effects


3.      Roche’s Ocrelizumab Found to be Superior to Standard Interferon Therapy in Relapsing Multiple Sclerosis Patients


4.      Biogen to Present New Data at Upcoming ECTRIMS 2015 Congress on MS Therapies, Including TECFIDERA


5.      EMD Serono To Present New Data on Rebif, a Therapy for RRMS, at Upcoming ECTRIMS Congress


6.      Receptos Launches SUNBEAM Phase 3 Trial for Relapsing Multiple Sclerosis Therapy


7.      Gut Bacteria: Key to MS?


8.      Most MS Survey Respondents Favor Legal Marijuana Access For Medical Use


9.      Stem Cells Used to Treat Secondary Progressive Patients in Clinical Trial


10.    Study Supports High Intensity Exercise to Improve Muscle Condition in MS Patients


Updates on #ECTRIMS2015

Tagged .

Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.
Click here to receive MS news via e-mail

Leave a Comment

Your email address will not be published. Required fields are marked *